Walleye Capital’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.8K | Buy |
+11,406
| New | +$72.8K | ﹤0.01% | 1584 |
|
|
2025
Q1 | – | Sell |
-5,993
| Closed | -$57.3K | – | 1959 |
|
|
2024
Q4 | $57.3K | Sell |
5,993
-18,265
| -75% | -$175K | ﹤0.01% | 1765 |
|
|
2024
Q3 | $203K | Sell |
24,258
-72,349
| -75% | -$604K | ﹤0.01% | 1695 |
|
|
2024
Q2 | $659K | Buy |
96,607
+65,607
| +212% | +$447K | ﹤0.01% | 1327 |
|
|
2024
Q1 | $78.4K | Sell |
31,000
-238,690
| -89% | -$604K | ﹤0.01% | 2059 |
|
|
2023
Q4 | $647K | Buy |
269,690
+227,596
| +541% | +$546K | ﹤0.01% | 1069 |
|
|
2023
Q3 | $143K | Sell |
42,094
-142,404
| -77% | -$484K | ﹤0.01% | 1578 |
|
|
2023
Q2 | $1.36M | Buy |
184,498
+75,921
| +70% | +$558K | ﹤0.01% | 632 |
|
|
2023
Q1 | $1.12M | Buy |
108,577
+25,575
| +31% | +$265K | 0.02% | 712 |
|
|
2022
Q4 | $980K | Buy |
83,002
+77,571
| +1,428% | +$916K | 0.02% | 735 |
|
|
2022
Q3 | $114K | Sell |
5,431
-8,342
| -61% | -$175K | ﹤0.01% | 1639 |
|
|
2022
Q2 | $428K | Buy |
+13,773
| New | +$428K | 0.01% | 1103 |
|
|
2021
Q3 | – | Sell |
-7,050
| Closed | -$444 | – | 1617 |
|
|
2021
Q2 | $444 | Buy |
+7,050
| New | +$444 | 0.02% | 784 |
|
|
2018
Q3 | $227K | Buy |
+3,445
| New | +$227K | 0.11% | 189 |
|